Mangoceuticals, Inc. (MGRX) Financial Statements

Mangoceuticals, Inc.'s market cap is currently $16.69M. The company's EPS TTM is $-4.522; its P/E ratio is -0.42; Mangoceuticals, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.